FindTrial
Sign In

VATS vs. open lobectomy for resectable SCLC: a real-world cohort study using PSM analysis

VATS vs. open lobectomy for localized SCLC: a real-world cohort study using PSM analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090367
Enrollment
Unknown
Registered
2024-09-29
Start date
2024-09-29
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

VATS group:None
Open thoracic surgery group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: From November 2005 to November 2021, underwent radical resection of lung cancer at the Department of Thoracic Surgery, West China Hospital, Sichuan University; Postoperative pathological diagnosis was small cell lung cancer; Perform lobectomy;

Exclusion criteria

Exclusion criteria: Incomplete clinical medical records or follow-up information; Patients with stage M1 or N3 according to the 9th edition of AJCC; Accompanied by other malignant tumors and already treated before diagnosis of small cell lung cancer; Underwent robotic-assisted thoracic surgery.

Design outcomes

Primary

MeasureTime frame
Overall survival ;Disease-free survival;—

Secondary

MeasureTime frame
Intra-operative blood loss;hospital stay;Complication rate;number of lymph node harvested;—

Countries

China

Contacts

Public ContactLunxu Liu

West China Hospital, Sichuan University

lunxu_liu@aliyun.com+86 189 8060 1525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026